From NVIDIA: 2024-11-12 21:09:58

Japan is utilizing sovereign AI initiatives to enhance healthcare, with AI tools aiding clinicians and researchers to care for patients. Breakthrough technology deployments in drug discovery, genomics, imaging, and robotics are showcased at the NVIDIA AI Summit in Tokyo. NVIDIA platforms like BioNeMo and Parabricks are accelerating medical advancements in Japan’s healthcare industry.

NVIDIA’s BioNeMo platform is supporting Japan’s pharmaceutical market with AI models like AlphaFold2, DiffDock, and RFdiffusion for drug discovery research. BioNeMo Blueprints and NIM microservices optimize AI inference for biological intelligence generation. The platform accelerates chemical molecule generation by over 30 times and enables faster protein structure predictions.

Japanese pharma companies like Astellas, Daiichi-Sankyo, and Ono Pharmaceutical are utilizing the Tokyo-1 NVIDIA DGX supercomputer for drug discovery. Xeureka is exploring confidential computing with NVIDIA H100 GPUs to enhance collaboration on AI model training. Genomics researchers are using NVIDIA Parabricks for DNA and RNA analysis, aiding precision medicine developments.

Healthcare innovators in Japan are developing AI systems to support radiologists and surgeons, like Fujifilm’s AI application for surgery support. Olympus collaborated with NVIDIA and NTT for cloud-connected endoscopes with AI applications powered by NVIDIA Jetson Orin modules. NVIDIA’s Holoscan platform is facilitating real-time AI insights for radiology and surgery applications in Japan.

Japanese companies are exploring the use of Holoscan for diagnostic support in endoscopy and surgery, potentially reducing injury risks and improving surgical efficiency. Digital health systems like NURA by Fujifilm are being developed with AI-augmented medical examinations for faster cancer and chronic disease screenings. NVIDIA technology like DGX systems and RTX GPUs are powering these advancements in Japan’s healthcare industry.



Read more at NVIDIA: Japan Develops AI-Powered Drug Design, Healthcare Robotics, Digital Health Platforms